Amgen Inc. buy phonebroker
Start price
29.04.21
/
40%
€196.62
Target price
29.04.22
€217.00
Performance (%)
-3.11%
End price
23.08.21
€190.50
Summary
This prediction ended on 23.08.21 with a price of €190.50. With a performance of -3.11%, the BUY prediction by phonebroker finished with a loss. A total of €2.95 was paid as dividends for this prediction. phonebroker has 40% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | 2.386% | 2.386% | 10.744% | 9.669% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% | 70.602% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% | 103.322% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% | 44.593% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% | 64.741% |
Comments by phonebroker for this prediction
In the thread Amgen Inc. diskutieren
Buy Amgen Inc.
Kursziel gesetzt auf 217,0